U.S. Hospital Sales Opportunities Maximized Through Functional Op... ( CHAPEL HILL N.C. Aug. 15 /- The U...)

U.S. Hospital Sales Opportunities Maximized Through Functional Optimization

Date:8/15/2008

CHAPEL HILL, N.C., Aug. 15 /PRNewswire/ -- The U.S. hospital marketplace is multifaceted and can be divided into multiple market segments. In this challenging marketplace, pharmaceutical and biotechnology sales people must negotiate increasingly complex organizational and decision-making structures to effectively represent their brands. Hospital formulary decisions are not only being influenced by medical professionals focused on efficacy and safety but also by administrative personnel focused on operational efficiency and cost. Impactful benchmark research originally conducted by Best Practices, LLC in 2006 focused on understanding the variables in developing an effective sales force to service the hospital marketplace has been updated and published with comparisons drawn between current and historical data as appropriate.

In a benchmarking study that included such influential companies as Abbott, Astra Zeneca, Bayer, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, Procter & Gamble, Sanofi-Aventis, Schering-Plough, and Wyeth, key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.

For a complimentary summary of the full report "Sales Force Effectiveness: Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace," click on the following link http://www3.best-in-class.com/rr970.htm .

Key topic areas in the research include:

-- Targeting Key Decision Makers and Influencers

-- Hospital Sales Force Alignment, Structure and Support

-- Hospital Sales Force Training

-- GPO Focus

-- Lessons Learned

For more information on this report, contact Robert Naylor at rnaylor@best-in-class.com or (919) 767-9244. To access the full report or download a complimentary copy of the report summary
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
3. Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital
4. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
7. Candid Details on Hospitals Quality of Care Are Now at Your Fingertips - Just Like It Should Be
8. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
9. Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0
10. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
11. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs

Post Your Comments:

(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...

(Date:6/18/2013)... Philadelphia, PA (PRWEB) June 18, 2013 ... fiber-optic Ball Lenses engineered of synthetic Sapphire and Glass ... stock sizes from Swiss Jewel Company , of ... performance by expanding and collimating the light beams without ... extreme optical clarity and natural durability (9 mohs) make ...

(Date:6/18/2013)... , June 18, 2013 RegeneCure ... the company,s proprietary AMCA Guided Bone Regeneration (GBR) Dental Membrane ... A common problem encountered when patients have a ... sufficient bone volume to house the implant. Consequently there is ... substitute until the natural bone regenerates. The bone substitute material, ...

(Date:6/18/2013)... N.Y. , June 18, 2013 AMRI ... its Burlington, Mass. , site ... Drug Enforcement Administration (DEA) registration to handle Schedule ... the DEA,s acknowledgement of Burlington,s ... control and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors [0] RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants [0] AMRI Burlington Receives DEA Approval to Handle Controlled Substances

... Sept. 18 /PRNewswire-FirstCall/-- Biodel Inc. (Nasdaq:,BIOD) today ... program,at the 43rd Scientific Sessions of the ... VIAject(TM) Phase II meal study data ... entitled, "Pharmacokinetics and pharmacodynamics of,insulin VIAject(TM), insulin ...

... Advantage of ... after HIV Infection, RICHMOND, Calif., Sept. 18 /PRNewswire-FirstCall/ ... the presentation of data,demonstrating that human CD4 T-cells can ... zinc finger DNA-binding protein nucleases,(ZFN(TM)) and preferentially survive and ...

... the Increasing Global Need for Genzyme Products, CAMBRIDGE, ... today broke ground on a significant expansion of its,flagship ... project is focused on adding space for manufacturing support,functions, ... The expansion was marked by a ceremony featuring ...

Cached Biology Technology:Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 2 Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 3 Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 2 Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 3 Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 4 Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 5 Genzyme Begins Major Expansion of Boston Manufacturing Facility 2 Genzyme Begins Major Expansion of Boston Manufacturing Facility 3 Genzyme Begins Major Expansion of Boston Manufacturing Facility 4 Genzyme Begins Major Expansion of Boston Manufacturing Facility 5

Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic Genzyme Begins Major Expansion of Boston Manufacturing Facility

(Date:6/18/2013)... PARIS , June 19, 2013 Paris ... known as Geotest-Marvin Test Systems) , a leading ... commercial aerospace industries, is demonstrating its solutions this ... in booth 3-C82. With growing challenges including increasingly ... are demanding efficient, feature-rich, specialized aerospace test solutions ...

(Date:6/18/2013)... Scientists at the University of Calgary,s Faculty of Medicine ... the body from harmful bacteria. Platelets, a component of ... search for specific bacteria, and upon detection, seal it ... which were published in Nature Immunology this ... of immunity. , "The science community has known that ...

(Date:6/18/2013)... Energy Department,s National Renewable Energy Laboratory (NREL), and ... paper describing a novel cellulose-degrading enzyme from a ... known as the gribble. , Gribbles are ... ability to produce their own enzymes instead of ... they eat. New biomass-degrading enzymes from novel sources ...

Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2 Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3 Immunity mechanism discovered 2 Novel enzyme from tiny gribble could prove a boon for biofuels research 2

[0] Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show [0] Immunity mechanism discovered [0] Novel enzyme from tiny gribble could prove a boon for biofuels research

... more than 10 years of cooperative research on ... the USDA Forest Service,s Pacific Southwest Research Station ... Phytophthora ramorum : A Summary of the Literature." ... of topics, including a history of sudden oak ...

... Vegas, NV (Dec. 24, 2010) - Three weeks of ... heart attack returned microRNA activity close to their pre-event ... studied, just six were attributed to exerting the majority ... study four microRNA optimally regulated by Longevinex and ...

... An expert working group of the International ... Clinical Chemistry and Laboratory Medicine (IFCC) has released ... of bone turnover markers (BTMs) in fracture risk ... it identifies research priorities and recommends that specific ...

Cached Biology News:Comprehensive report on sudden oak death 2 Longevinex exerts greater influence over genes than resveratrol 2 Longevinex exerts greater influence over genes than resveratrol 3 Standardized protocols would greatly enhance clinical and research potential of BTMs 2

Comprehensive report on sudden oak death Longevinex exerts greater influence over genes than resveratrol Standardized protocols would greatly enhance clinical and research potential of BTMs

This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (E6027) or contact customer s...

... Analysis of large numbers of samples may be ... requires minimum operator attention. System control and ... interface CE 4900. The elegant, powerful and ... XP and Windows 98 and 2000., The supplied ...

Narrow-mouth has heavy-duty rim. Approximate graduations are in durable white enamel. Extra large marking space. capacity 125 mL Special grade: student grade...

... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of human YBX2. (Note: the ... Entrez ...

Biology Products:

Corning 2000 ml Erlenmeyer Flask, Pc, Sterile from Sigma-Aldrich Adept HPLC System 3S, Automatic Isocratic from Cecil Instruments Ltd.Pyrex brand narrow mouth graduated erlenmeyer flask, student grade from Sigma-Aldrich Rabbit Anti-Human MSY2 / YBOX2 Polyclonal Antibody, Unconjugated from Abcam